Figures & data
Table 1. Overview of work packages and their short and long-term impact.
Figure 1. Microcephaly Epidemic Research Group (MERG), Neuro-Zika, and the clinical sites of the Butantan Phase 3 trial for dengue vaccine.
![Figure 1. Microcephaly Epidemic Research Group (MERG), Neuro-Zika, and the clinical sites of the Butantan Phase 3 trial for dengue vaccine.](/cms/asset/8809daf0-346e-49f8-a469-80635782f7fe/zgha_a_1666566_f0001_oc.jpg)
Table 2. Scientific publications by the Microcephaly Epidemic Research Group (MERG) in North-East Brazil and ZikaPLAN Work Package 1 Partners, from 2015 to present.
Table 3. Web-based information that ZikaPLAN has made publicly available.